Human papilloma virus vaccination programs reduce health inequity in most scenarios: A simulation study

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Crowcroft, Natasha S ^a,b,c   Hamid, Jemila S ^a,d   Deeks, Shelley L ^a,c   Frank, John ^c,e,f  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e Scottish Collaboration for Public Health Research and Policy   (Canada)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; COMPUTER SIMULATION; EARLY DIAGNOSIS; FEMALE; HEALTH CARE QUALITY; HEALTH DISPARITY; HUMAN; METHODOLOGY; PAPILLOMAVIRUS INFECTION; PREVENTIVE HEALTH SERVICE; RISK ASSESSMENT; THEORETICAL MODEL; UTERINE CERVIX TUMOR; UTILIZATION REVIEW;

COMPUTER SIMULATION; EARLY DETECTION OF CANCER; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; IMMUNIZATION PROGRAMS; MODELS, THEORETICAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PROGRAM EVALUATION; RISK ASSESSMENT; UTERINE CERVICAL NEOPLASMS;

EID: 84868217116     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-935     Document Type: Article

References (26)

1. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. Gakidou E, Nordhagen S, Obermeyer Z, PLoS Med 2008 17 5(6)
2. Health equity, HPV and the cervical cancer vaccine. Erdman JN, Health Law J 2008 127 143 http://papers.ssrn.com/sol3/papers.cfm?abstract-id=1372864 accessed 25th April 2011
3. Vaccination against human papillomavirus. Franco EL, de Pokomandy A, Spence AR, Burchell AN, Trottier H, Mayrand MH, Lau S, CMAJ 2007 177 12 1524 1525 18056601
4. The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Brisson M, Van De Velde N, De Wals P, Boily MC, Vaccine 2007 25 29 5399 5408 Epub 2007 May 22 10.1016/j.vaccine.2007.04.086 17561316 (Pubitemid 46977529)
5. Human papillomavirus and HPV vaccines: a review. Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L, Bull World Health Organ 2007 85 9 719 726 10.2471/BLT.06.038414 18026629 (Pubitemid 47416724)
6. Parental intention to have daughters receive the human papillomavirus vaccine. Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak KL, Ehlen TG, Dobson SR, Money DM, Patrick DM, CMAJ 2007 177 12 1506 1512 10.1503/cmaj.071022 18056599 (Pubitemid 350248162)
7. Human papillomavirus, vaccines and women's health: questions and cautions. Lippman A, Melnychuk R, Shimmin C, Boscoe M, CMAJ 2007 177 5 484 487 10.1503/cmaj.070944 17671239 (Pubitemid 47359772)
8. The cervical cancer epidemic that screening has prevented in the UK. Peto J, Gilham C, Fletcher O, Matthews FE, Lancet 2004 364 9430 249 256 10.1016/S0140-6736(04)16674-9 15262102 (Pubitemid 38942814)
9. Cervical cancer incidence can increase despite HPV vaccination. Harper DM, Nieminen P, Paavonen J, Lehtinen M, Lancet Infect Dis 2010 10 9 594 595 10.1016/S1473-3099(10)70182-1 20797640
10. Cervical cancer mortality by neighbourhood income in urban Canada from 1971 to 1996. Ng E, Wilkins R, Fung MF, Berthelot JM, CMAJ 2004 170 1545 1549 10.1503/cmaj.1031528 15136547 (Pubitemid 38686185)
11. Cervical cancer mortality in Australia: contrasting risk by Aboriginality, age and rurality. O'Brien ED, Bailie RS, Jelfs PL, Int J Epidemiol 2000 29 813 816 10.1093/ije/29.5.813 11034962
12. Immigrant women and cervical cancer screening uptake: a multilevel analysis. Woltman KJ, Newbold KB, Can J Public Health 2007 98 470 475 19039885
13. Vaccination against human papillomavirus. Cassels AK, CMAJ 2007 177 12 1526 18056605
14. Epidemiology of rubella and congenital rubella syndrome in Greece, 1994-2003. Panagiotopoulos T, Georgakopoulou T, Euro Surveill 2004 9 4 17 19 15318007
15. Changing socioeconomic risk factors for invasive H. influenzae disease after the introduction of conjugate vaccine. Olowokure B, Spencer NJ, Hawker JI, Blair I, Smith RL, J Infect 2003 46 1 46 48 10.1053/jinf.2002.1069 12504608 (Pubitemid 37266028)
16. World Health Organization Commission Report, Closing the gap in a generation: Health equity through action on the social determinants of health http://www.who.int/social-determinants/thecommission/finalreport/en/index.html. Accessed 18th August 2011
17. The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Massad LS, Einstein M, Myers E, Wheeler CM, Wentzensen N, Solomon D, Gynecol Oncol 2009 114 2 360 364 Epub 2009 May 1 10.1016/j.ygyno. 2009.04.005 19410282
18. Canada.com website reporting a Reuters survey http://www.canada.com/ topics/lifestyle/relationships/story.html?id=82b56024-77ff-4aef-a4ec- 05c247d1e3f0. Accessed 24th March 2012
19. Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection. Brisson M, Van De Velde N, De Wals P, Boily MC, CMAJ 2007 177 5 464 468 Epub 2007 Aug 20 10.1503/cmaj.061709 17709404 (Pubitemid 47359769)
20. Economic evaluation of human papillomavirus vaccination in the United Kingdom. Jit M, Choi YH, Edmunds WJ, BMJ 2008 337 769 10.1136/bmj.a769 18640957
21. The cost effectiveness of human papillomavirus vaccines: a systematic review. Seto K, Marra F, Raymakers A, Marra CA, Drugs 2012 72 5 715 743 10.2165/11599470-000000000-00000 22413761
22. New South Wales Health HPV Adverse Events Panel. Anaphylaxis following quadrivalent human papillomavirus vaccination. Brotherton JM, Gold MS, Kemp AS, McIntyre PB, Burgess MA, Campbell-Lloyd S, CMAJ 2008 179 6 525 533 Epub 2008 Sep 1 10.1503/cmaj.080916 18762618
23. R Development Core Team, R: A language and environment for statistical computing, 2008 R Foundation for Statistical Computing, Vienna, Austria ISBN 3-900051-07-0, URL http://www.R-project.org. Website accessed 24th March 2012
24. Chan EOM, Dolman S, Fung C, Ontario Ministry of Health and Long-Term Care, Public Health Division, Immunization coverage report for school pupils: School years 2007/2008 and 2008/2009 2011
25. Model-based estimation of viral transmissibility and infection-induced resistance from the age-dependent prevalence of infection for 14 high-risk types of human papillomavirus. Bogaards JA, Xiridou M, Coupé VM, Meijer CJ, Wallinga J, Berkhof J, Am J Epidemiol 2010 171 7 817 825 10.1093/aje/kwp466 20231211
26. Inequalities in cancer screening programmes. Sarfati D, Shaw C, Simmonds S, Int J Epidemiol 2010 39 3 766 768 Epub 2010 Mar 9 10.1093/ije/dyq039 20215427